| DE3635522A1 (de)* | 1986-10-18 | 1988-04-28 | Euro Celtique Sa | Pharmazeutische zusammensetzung |
| JPH0653672B2 (ja)* | 1987-12-23 | 1994-07-20 | プソリツル・リミテッド | 乾癬に対する治療用組成物 |
| GB9100581D0 (en)* | 1991-01-11 | 1991-02-27 | Rhodes Technology | Method for the extraction of sesquiterpene lactones |
| DE4202657C2 (de)* | 1992-01-31 | 1995-10-12 | Schaper & Bruemmer Gmbh | Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel |
| US5576329A (en)* | 1992-07-24 | 1996-11-19 | Hennessey; Richard K. | Method for treating tendon or joint inflammation with papaverine HCL |
| US5278172A (en)* | 1992-07-24 | 1994-01-11 | Hennessey Richard K | Method and composition for treating tendon or joint inflammation using a vasodilator |
| CN1056142C (zh)* | 1993-01-04 | 2000-09-06 | 昆明医学院第一附属医院 | 水朝阳内酯的制备方法 |
| CA2141126A1 (en)* | 1995-01-26 | 1996-07-27 | Natalie J. Lazarowych | Combinational drug for treating migraine and other illnesses |
| US6379714B1 (en) | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
| US5665731A (en)* | 1995-06-07 | 1997-09-09 | Hennessey; Richard K. | Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal |
| DE69709691T2 (de) | 1996-10-21 | 2002-08-22 | Morten Sloth Weidner | Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium |
| US5905089A (en)* | 1997-04-14 | 1999-05-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of sesquiterpene lactones for treatment of severe inflammatory disorders |
| US5972916A (en)* | 1997-07-14 | 1999-10-26 | Bristol-Myers Squibb Company | Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine |
| AU1573499A (en)* | 1997-12-23 | 1999-07-19 | Moser, Rene | Sesquiterpene lactones specifically inhibit activation of nf-k B by preventing the degradation of IkB-alpha and IkB-beta |
| US6225339B1 (en)* | 1998-01-29 | 2001-05-01 | Pfizer Inc. | Terpenoid lactone compounds and their production process |
| US6068999A (en)* | 1998-06-25 | 2000-05-30 | Hendrix; Curt | Dietary supplement for supporting cerebrovascular tone and treating migraine headaches |
| US6221899B1 (en) | 1999-01-15 | 2001-04-24 | Pfizer Inc. | Terpenoid lactone compounds and their production process |
| IT1312342B1 (it) | 1999-06-03 | 2002-04-15 | Indena Spa | Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi. |
| US20030003170A1 (en)* | 2000-06-02 | 2003-01-02 | Theresa Callaghan | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
| CN1319020A (zh) | 1999-06-03 | 2001-10-24 | 约翰逊及约翰逊法国消费者有限公司 | 抗炎症性疾病的野甘菊提取物 |
| US6642243B1 (en) | 1999-07-22 | 2003-11-04 | Ashkan Imanzahrai | Migraine medicine and method for treating same |
| DE10015617A1 (de)* | 2000-03-29 | 2001-10-04 | Peter Laetzsch | Migränemittel |
| IN188857B (da)* | 2000-07-14 | 2002-11-16 | Govind Kane Dr Shantaram | |
| BR0208123A (pt)* | 2001-03-16 | 2004-03-09 | Johnson & Johnson Consumer | Composição contendo extrato de matricária e seu uso |
| US20030077343A1 (en)* | 2001-03-16 | 2003-04-24 | Martin Katharine M. | Composition containing feverfew extract and use thereof |
| US20040086579A1 (en)* | 2002-11-05 | 2004-05-06 | Higgins James W. | Dietary supplement comprising parthenolide |
| US7192614B2 (en) | 2002-11-05 | 2007-03-20 | Gelstat Corporation | Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| US20040219229A1 (en)* | 2003-04-30 | 2004-11-04 | Tim Clarot | Migraine relief composition and methods of using and forming same |
| US20040247705A1 (en)* | 2003-06-06 | 2004-12-09 | Roberts Stephen C. | Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| US20040247706A1 (en)* | 2003-06-06 | 2004-12-09 | Roberts Stephen C. | Transdermal dietary supplement comprising parthenolide |
| US7678904B2 (en) | 2003-07-11 | 2010-03-16 | University Of Kentucky | Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| US20050186269A1 (en)* | 2004-02-25 | 2005-08-25 | Udell Ronald G. | Stabilized feverfew formulations |
| US20060222722A1 (en)* | 2005-03-30 | 2006-10-05 | Roberts Stephen C | Sublingual methods of treatment to alleviate or prevent arthritis |
| US8409637B2 (en)* | 2007-06-21 | 2013-04-02 | Puramed Bioscience Inc. | Compositions and methods for treating and preventing migrainous headaches and associated symptoms |
| US10500182B2 (en)* | 2018-01-10 | 2019-12-10 | Robert Firger | Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache |
| CN109761994B (zh)* | 2019-02-28 | 2021-06-29 | 中国科学院新疆理化技术研究所 | 降碳类愈创木烷型倍半萜内酯类化合物及其制备方法 |